Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • buthercup_ch
    Member
    • Apr 2014
    • 41

    #1

    5S rRNA contamination

    Hi everyone.

    I'm new in this world of NGS and HTS and I need some help in understanding some issues.
    I've just received a set of sequences from RNA-Seq in Illumina Platform. I personally prepared the cDNA library to be used in the sequencing reaction, starting from total RNA from gram-negative bacterial.
    To get rid of the rRNA I used RiboZero kit (for gram-negative bacteria) and the treatment was really successful, except for low amounts of 5S rRNA that still remains. But it seems that is something normal using this kit.
    The expert from the Genome Platform and my supervisor agreed in continuing with the sequencing, and it turns out that the final data contains "5S rRNA contamination"…, what is not a surprise, of course.
    I use CLC Workbench Genomics to run the data analysis. After QC analysis, sequencing seemed to be of very good quality. And after trimming, I obtained about 40% of unmapped reads, what seems reasonable. The mapping was against a Reference Genome downloaded from NCBI, containing only the chromosome.
    I run the analysis to compare "non-specific matches" (max hits = 10) and "specific matches" (max hits =1)… and in both cases I obtained a huge amount of reads that map with a small region, of about 119bp of the 5S rRNA subunit of 1 of the 5 operons that exists.
    Running a RNA-Seq analysis against the same genome, but using "rRNA" track, instead "genes" or "CDS" tracks, I obtained a mapping of about 18% to the same region.

    The question is the following. Should I be worried about the accuracy of the RNA-Seq experiment due to this contamination of 5S? Should I repeat the sequencing reaction after getting rid completely of the remaining 5S rRNA in the samples? Or in contrast, could I use the expression value obtained if I just eliminate tRNAs and rRNAs from the Reference Genome (running the analysis agains a multicast file of all genes gave almost the same result than the aligned genome)

    Thank you very much in advance
  • buthercup_ch
    Member
    • Apr 2014
    • 41

    #2
    An additional information:
    Comparing the analysis against "all genes" (including CDS, tRNA and rRNA genes) or "only CDS", the % of not mapped reads rise from about 40 to about 60%…, logical if we take into account about 18% mapping if we only consider rRNA gene sequences to perform the analysis.
    But…., is that 60% not mapped reads to high????

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
      by SEQadmin2



      CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

      Despite this, “CRISPR helped turn genome editing from a specialized technique into
      ...
      07-31-2026, 11:01 AM
    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 07-31-2026, 02:55 AM
    0 responses
    18 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    16 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-23-2026, 11:41 AM
    0 responses
    16 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    26 views
    0 reactions
    Last Post SEQadmin2  
    Working...